BioAge Labs, Inc.

BIOA · Nasdaq · SIC 2834: Pharmaceutical Preparations
29
SEC Filings

Business Summary

PART I . Overview We are a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. Our technology platform and differentiated human datasets enable us to identify promising targets based on insights into molecular changes that drive aging. In January 2025, we announced the nomination of our lead program, BGE-102, a potent, structurally novel, orally available, brain-penetrant small-molecule NLRP3 inhibitor...

Next Earnings

Q2 FY2026 — expected 2026-08-16

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionBIOAdiscussed_in_filing Cybersecurity
topic_mentionBIOAdiscussed_in_filing Cybersecurity
topic_mentionBIOAdiscussed_in_filing Healthcare & Bio
topic_mentionBIOAdiscussed_in_filing Platform & Ecosystem
topic_mentionBIOAdiscussed_in_filing Healthcare & Bio
topic_mentionBIOAdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-242025-12-310001193125-26-120873EDGAR94K words
2025-03-202024-12-310000950170-25-042759EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001193125-25-270012EDGAR67K words
2025-08-062025-06-300000950170-25-104176EDGAR—
2025-05-062025-03-310000950170-25-064552EDGAR—
2024-11-072024-09-300000950170-24-123445EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-240001193125-26-120864EDGAR3K words
2026-01-220001193125-26-019536EDGAR—
2026-01-200001193125-26-016046EDGAR—
2026-01-120001193125-26-009911EDGAR—
2025-12-040001193125-25-307541EDGAR—
2025-11-060001193125-25-269986EDGAR—
2025-08-060000950170-25-104151EDGAR—
2025-06-090000950170-25-083746EDGAR—
2025-06-040000950170-25-081409EDGAR—
2025-05-060000950170-25-064547EDGAR—

29 total filings indexed. 13 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001709941
TickerBIOA
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 098a0a7dd341c9c5c3117cced25f5f5b927dec640845fd505d31c41380af9e45
parent: 0825ed59a04c8d868d25d0485ce490fd389a1ac0b25301fb5d647e25cef911ef
content hash: 8ccd348cc8f07b6d4e0dba65283f0393da2f0c42bfe84fe66bc4800f2222858c
signed: 2026-04-13T04:43:58.273Z
sources: 6 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf